Literature DB >> 10647747

Regulation of the formation and external transport of secretory immunoglobulins.

I N Norderhaug1, F E Johansen, H Schjerven, P Brandtzaeg.   

Abstract

Secretory IgA (SIgA) is the best defined effector component of the mucosal immune system. Generation of SIgA and secretory IgM (SIgM) in exocrine glands and mucous membranes depends on a fascinating cooperation between local plasma cells that produce polymeric IgA (pIgA, mainly dimers and some larger polymers) and pentameric IgM, and secretory epithelial cells that express the polymeric Ig receptor (pIgR)--also known as transmembrane secretory component. After release from the local plasma cells and diffusion through the stroma, pIgA and pentameric IgM become readily bound to pIgR, and are then actively transported across secretory epithelial cells for extrusion into external secretions after cleavage of pIgR. Much knowledge has recently been obtained at the molecular level about the regulation of pIgR-mediated transport of antibodies. This mechanism is of considerable biological interest because SIgA and SIgM form the first line of specific immunological defense against infectious agents and other harmful substances that may enter the body through the mucosae.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10647747

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  49 in total

Review 1.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

2.  Psychological distress and salivary secretory immunity.

Authors:  C G Engeland; F N Hugo; J B Hilgert; G G Nascimento; R Junges; H-J Lim; P T Marucha; J A Bosch
Journal:  Brain Behav Immun       Date:  2015-08-28       Impact factor: 7.217

3.  Proinflammatory cytokine surge after injury stimulates an airway immunoglobulin a increase.

Authors:  Mark A Jonker; Yoshifumi Sano; Joshua L Hermsen; Jinggang Lan; Kenneth A Kudsk
Journal:  J Trauma       Date:  2010-10

4.  Analysis of gene expression identifies candidate molecular markers in nasopharyngeal carcinoma using microdissection and cDNA microarray.

Authors:  Zhaoyang Zeng; Yanhong Zhou; Wei Xiong; Xiaomin Luo; Wenling Zhang; Xiaoling Li; Songqing Fan; Li Cao; Ke Tang; Minghua Wu; Guiyuan Li
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-21       Impact factor: 4.553

5.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

6.  Bombesin improves adaptive immunity of the salivary gland during parenteral nutrition.

Authors:  Joseph F Pierre; Aaron F Heneghan; Xinying Wang; Drew A Roenneburg; Guy E Groblewski; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2013-10-11       Impact factor: 4.016

7.  Reduced expression of polymeric immunoglobulin receptor (pIgR) in nasopharyngeal carcinoma and its correlation with prognosis.

Authors:  Xuanchang Qi; Xuechang Li; Xiuxia Sun
Journal:  Tumour Biol       Date:  2016-02-24

Review 8.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

9.  Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies.

Authors:  M Jack Borrok; Antonio DiGiandomenico; Nurten Beyaz; Gabriela M Marchetti; Arnita S Barnes; Kristen J Lekstrom; Sandrina S Phipps; Michael P McCarthy; Herren Wu; William F Dall'Acqua; Ping Tsui; Ruchi Gupta
Journal:  JCI Insight       Date:  2018-06-21

10.  Gut Lymphocyte Phenotype Changes After Parenteral Nutrition and Neuropeptide Administration.

Authors:  Mark A Jonker; Aaron F Heneghan; John H Fechner; Joseph F Pierre; Yoshifumi Sano; Jinggang Lan; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2015-07       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.